Global Lou Gehrigs Disease Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Amyotrophic lateral sclerosis (ALS), also known as motor neurone disease (MND), or Lou Gehrig's disease, is a specific disease which causes the death of neurons controlling voluntary muscles. Some also use the term motor neuron disease for a group of conditions of which ALS is the most common.
SCOPE OF THE REPORT:
This report focuses on the Lou Gehrigs Disease in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Lou Gehrigs Disease is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe Lou Gehrigs Disease Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Lou Gehrigs Disease, with sales, revenue, and price of Lou Gehrigs Disease, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Lou Gehrigs Disease, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Lou Gehrigs Disease market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Lou Gehrigs Disease sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
SCOPE OF THE REPORT:
This report focuses on the Lou Gehrigs Disease in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Lou Gehrigs Disease is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- AB Science
- Avicena Group
- Biogen
- BrainStorm Therapeutics
- Covis Pharmaceutical Inc.
- Cytokinetics Inc.
- Eisai Co. Ltd.
- GlaxoSmithKline plc.
- Ionis Pharmaceuticals, Inc.
- Mitsubishi Tanabe Pharma Corp.
- Neuralstem Inc.
- Neuraltus Pharmaceuticals Inc.
- Newron Pharmaceuticals S.p.A.
- Nutra Pharma Corp.
- Pharnext SAS
- Q-Therapeutics Inc.
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Riluzole
- Edaravone (Radicava)
- Hospital Pharmacies
- Retail & Online Pharmacie
Chapter 1, to describe Lou Gehrigs Disease Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Lou Gehrigs Disease, with sales, revenue, and price of Lou Gehrigs Disease, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Lou Gehrigs Disease, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Lou Gehrigs Disease market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Lou Gehrigs Disease sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW
1.1 Lou Gehrigs Disease Introduction
1.2 Market Analysis by Type
1.2.1 Riluzole
1.2.2 Edaravone (Radicava)
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacies
1.3.2 Retail & Online Pharmacie
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 AB Science
2.1.1 Business Overview
2.1.2 Lou Gehrigs Disease Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AB Science Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Avicena Group
2.2.1 Business Overview
2.2.2 Lou Gehrigs Disease Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Avicena Group Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Biogen
2.3.1 Business Overview
2.3.2 Lou Gehrigs Disease Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biogen Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 BrainStorm Therapeutics
2.4.1 Business Overview
2.4.2 Lou Gehrigs Disease Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 BrainStorm Therapeutics Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Covis Pharmaceutical Inc.
2.5.1 Business Overview
2.5.2 Lou Gehrigs Disease Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Covis Pharmaceutical Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Cytokinetics Inc.
2.6.1 Business Overview
2.6.2 Lou Gehrigs Disease Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Cytokinetics Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Eisai Co. Ltd.
2.7.1 Business Overview
2.7.2 Lou Gehrigs Disease Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Eisai Co. Ltd. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 GlaxoSmithKline plc.
2.8.1 Business Overview
2.8.2 Lou Gehrigs Disease Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 GlaxoSmithKline plc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Ionis Pharmaceuticals, Inc.
2.9.1 Business Overview
2.9.2 Lou Gehrigs Disease Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Ionis Pharmaceuticals, Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Mitsubishi Tanabe Pharma Corp.
2.10.1 Business Overview
2.10.2 Lou Gehrigs Disease Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Mitsubishi Tanabe Pharma Corp. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Neuralstem Inc.
2.11.1 Business Overview
2.11.2 Lou Gehrigs Disease Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Neuralstem Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Neuraltus Pharmaceuticals Inc.
2.12.1 Business Overview
2.12.2 Lou Gehrigs Disease Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Neuraltus Pharmaceuticals Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Newron Pharmaceuticals S.p.A.
2.13.1 Business Overview
2.13.2 Lou Gehrigs Disease Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Newron Pharmaceuticals S.p.A. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Nutra Pharma Corp.
2.14.1 Business Overview
2.14.2 Lou Gehrigs Disease Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Nutra Pharma Corp. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Pharnext SAS
2.15.1 Business Overview
2.15.2 Lou Gehrigs Disease Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Pharnext SAS Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Q-Therapeutics Inc.
2.16.1 Business Overview
2.16.2 Lou Gehrigs Disease Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Q-Therapeutics Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL LOU GEHRIGS DISEASE SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)
3.1 Global Lou Gehrigs Disease Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Lou Gehrigs Disease Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Lou Gehrigs Disease Manufacturer Market Share in 2017
3.3.2 Top 6 Lou Gehrigs Disease Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 GLOBAL LOU GEHRIGS DISEASE MARKET ANALYSIS BY REGIONS
4.1 Global Lou Gehrigs Disease Sales, Revenue and Market Share by Regions
4.1.1 Global Lou Gehrigs Disease Sales and Market Share by Regions (2013-2018)
4.1.2 Global Lou Gehrigs Disease Revenue and Market Share by Regions (2013-2018)
4.2 North America Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
4.3 Europe Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
4.5 South America Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
5 NORTH AMERICA LOU GEHRIGS DISEASE BY COUNTRIES
5.1 North America Lou Gehrigs Disease Sales, Revenue and Market Share by Countries
5.1.1 North America Lou Gehrigs Disease Sales and Market Share by Countries (2013-2018)
5.1.2 North America Lou Gehrigs Disease Revenue and Market Share by Countries (2013-2018)
5.2 United States Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
5.3 Canada Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
5.4 Mexico Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
6 EUROPE LOU GEHRIGS DISEASE BY COUNTRIES
6.1 Europe Lou Gehrigs Disease Sales, Revenue and Market Share by Countries
6.1.1 Europe Lou Gehrigs Disease Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Lou Gehrigs Disease Revenue and Market Share by Countries (2013-2018)
6.2 Germany Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
6.3 UK Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
6.4 France Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
6.5 Russia Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
6.6 Italy Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
7 ASIA-PACIFIC LOU GEHRIGS DISEASE BY COUNTRIES
7.1 Asia-Pacific Lou Gehrigs Disease Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Lou Gehrigs Disease Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Lou Gehrigs Disease Revenue and Market Share by Countries (2013-2018)
7.2 China Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
7.3 Japan Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
7.4 Korea Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
7.5 India Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
8 SOUTH AMERICA LOU GEHRIGS DISEASE BY COUNTRIES
8.1 South America Lou Gehrigs Disease Sales, Revenue and Market Share by Countries
8.1.1 South America Lou Gehrigs Disease Sales and Market Share by Countries (2013-2018)
8.1.2 South America Lou Gehrigs Disease Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
8.3 Argentina Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
8.4 Colombia Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA LOU GEHRIGS DISEASE BY COUNTRIES
9.1 Middle East and Africa Lou Gehrigs Disease Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Lou Gehrigs Disease Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Lou Gehrigs Disease Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
9.3 UAE Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
9.4 Egypt Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
9.5 Nigeria Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
9.6 South Africa Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
10 GLOBAL LOU GEHRIGS DISEASE MARKET SEGMENT BY TYPE
10.1 Global Lou Gehrigs Disease Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Lou Gehrigs Disease Sales and Market Share by Type (2013-2018)
10.1.2 Global Lou Gehrigs Disease Revenue and Market Share by Type (2013-2018)
10.2 Riluzole Sales Growth and Price
10.2.1 Global Riluzole Sales Growth (2013-2018)
10.2.2 Global Riluzole Price (2013-2018)
10.3 Edaravone (Radicava) Sales Growth and Price
10.3.1 Global Edaravone (Radicava) Sales Growth (2013-2018)
10.3.2 Global Edaravone (Radicava) Price (2013-2018)
11 GLOBAL LOU GEHRIGS DISEASE MARKET SEGMENT BY APPLICATION
11.1 Global Lou Gehrigs Disease Sales Market Share by Application (2013-2018)
11.2 Hospital Pharmacies Sales Growth (2013-2018)
11.3 Retail & Online Pharmacie Sales Growth (2013-2018)
12 LOU GEHRIGS DISEASE MARKET FORECAST (2018-2023)
12.1 Global Lou Gehrigs Disease Sales, Revenue and Growth Rate (2018-2023)
12.2 Lou Gehrigs Disease Market Forecast by Regions (2018-2023)
12.2.1 North America Lou Gehrigs Disease Market Forecast (2018-2023)
12.2.2 Europe Lou Gehrigs Disease Market Forecast (2018-2023)
12.2.3 Asia-Pacific Lou Gehrigs Disease Market Forecast (2018-2023)
12.2.4 South America Lou Gehrigs Disease Market Forecast (2018-2023)
12.2.5 Middle East and Africa Lou Gehrigs Disease Market Forecast (2018-2023)
12.3 Lou Gehrigs Disease Market Forecast by Type (2018-2023)
12.3.1 Global Lou Gehrigs Disease Sales Forecast by Type (2018-2023)
12.3.2 Global Lou Gehrigs Disease Market Share Forecast by Type (2018-2023)
12.4 Lou Gehrigs Disease Market Forecast by Application (2018-2023)
12.4.1 Global Lou Gehrigs Disease Sales Forecast by Application (2018-2023)
12.4.2 Global Lou Gehrigs Disease Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
1.1 Lou Gehrigs Disease Introduction
1.2 Market Analysis by Type
1.2.1 Riluzole
1.2.2 Edaravone (Radicava)
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacies
1.3.2 Retail & Online Pharmacie
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 AB Science
2.1.1 Business Overview
2.1.2 Lou Gehrigs Disease Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AB Science Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Avicena Group
2.2.1 Business Overview
2.2.2 Lou Gehrigs Disease Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Avicena Group Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Biogen
2.3.1 Business Overview
2.3.2 Lou Gehrigs Disease Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biogen Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 BrainStorm Therapeutics
2.4.1 Business Overview
2.4.2 Lou Gehrigs Disease Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 BrainStorm Therapeutics Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Covis Pharmaceutical Inc.
2.5.1 Business Overview
2.5.2 Lou Gehrigs Disease Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Covis Pharmaceutical Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Cytokinetics Inc.
2.6.1 Business Overview
2.6.2 Lou Gehrigs Disease Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Cytokinetics Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Eisai Co. Ltd.
2.7.1 Business Overview
2.7.2 Lou Gehrigs Disease Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Eisai Co. Ltd. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 GlaxoSmithKline plc.
2.8.1 Business Overview
2.8.2 Lou Gehrigs Disease Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 GlaxoSmithKline plc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Ionis Pharmaceuticals, Inc.
2.9.1 Business Overview
2.9.2 Lou Gehrigs Disease Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Ionis Pharmaceuticals, Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Mitsubishi Tanabe Pharma Corp.
2.10.1 Business Overview
2.10.2 Lou Gehrigs Disease Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Mitsubishi Tanabe Pharma Corp. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Neuralstem Inc.
2.11.1 Business Overview
2.11.2 Lou Gehrigs Disease Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Neuralstem Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Neuraltus Pharmaceuticals Inc.
2.12.1 Business Overview
2.12.2 Lou Gehrigs Disease Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Neuraltus Pharmaceuticals Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Newron Pharmaceuticals S.p.A.
2.13.1 Business Overview
2.13.2 Lou Gehrigs Disease Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Newron Pharmaceuticals S.p.A. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Nutra Pharma Corp.
2.14.1 Business Overview
2.14.2 Lou Gehrigs Disease Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Nutra Pharma Corp. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Pharnext SAS
2.15.1 Business Overview
2.15.2 Lou Gehrigs Disease Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Pharnext SAS Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Q-Therapeutics Inc.
2.16.1 Business Overview
2.16.2 Lou Gehrigs Disease Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Q-Therapeutics Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL LOU GEHRIGS DISEASE SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)
3.1 Global Lou Gehrigs Disease Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Lou Gehrigs Disease Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Lou Gehrigs Disease Manufacturer Market Share in 2017
3.3.2 Top 6 Lou Gehrigs Disease Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 GLOBAL LOU GEHRIGS DISEASE MARKET ANALYSIS BY REGIONS
4.1 Global Lou Gehrigs Disease Sales, Revenue and Market Share by Regions
4.1.1 Global Lou Gehrigs Disease Sales and Market Share by Regions (2013-2018)
4.1.2 Global Lou Gehrigs Disease Revenue and Market Share by Regions (2013-2018)
4.2 North America Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
4.3 Europe Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
4.5 South America Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
5 NORTH AMERICA LOU GEHRIGS DISEASE BY COUNTRIES
5.1 North America Lou Gehrigs Disease Sales, Revenue and Market Share by Countries
5.1.1 North America Lou Gehrigs Disease Sales and Market Share by Countries (2013-2018)
5.1.2 North America Lou Gehrigs Disease Revenue and Market Share by Countries (2013-2018)
5.2 United States Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
5.3 Canada Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
5.4 Mexico Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
6 EUROPE LOU GEHRIGS DISEASE BY COUNTRIES
6.1 Europe Lou Gehrigs Disease Sales, Revenue and Market Share by Countries
6.1.1 Europe Lou Gehrigs Disease Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Lou Gehrigs Disease Revenue and Market Share by Countries (2013-2018)
6.2 Germany Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
6.3 UK Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
6.4 France Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
6.5 Russia Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
6.6 Italy Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
7 ASIA-PACIFIC LOU GEHRIGS DISEASE BY COUNTRIES
7.1 Asia-Pacific Lou Gehrigs Disease Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Lou Gehrigs Disease Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Lou Gehrigs Disease Revenue and Market Share by Countries (2013-2018)
7.2 China Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
7.3 Japan Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
7.4 Korea Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
7.5 India Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
8 SOUTH AMERICA LOU GEHRIGS DISEASE BY COUNTRIES
8.1 South America Lou Gehrigs Disease Sales, Revenue and Market Share by Countries
8.1.1 South America Lou Gehrigs Disease Sales and Market Share by Countries (2013-2018)
8.1.2 South America Lou Gehrigs Disease Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
8.3 Argentina Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
8.4 Colombia Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA LOU GEHRIGS DISEASE BY COUNTRIES
9.1 Middle East and Africa Lou Gehrigs Disease Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Lou Gehrigs Disease Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Lou Gehrigs Disease Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
9.3 UAE Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
9.4 Egypt Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
9.5 Nigeria Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
9.6 South Africa Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
10 GLOBAL LOU GEHRIGS DISEASE MARKET SEGMENT BY TYPE
10.1 Global Lou Gehrigs Disease Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Lou Gehrigs Disease Sales and Market Share by Type (2013-2018)
10.1.2 Global Lou Gehrigs Disease Revenue and Market Share by Type (2013-2018)
10.2 Riluzole Sales Growth and Price
10.2.1 Global Riluzole Sales Growth (2013-2018)
10.2.2 Global Riluzole Price (2013-2018)
10.3 Edaravone (Radicava) Sales Growth and Price
10.3.1 Global Edaravone (Radicava) Sales Growth (2013-2018)
10.3.2 Global Edaravone (Radicava) Price (2013-2018)
11 GLOBAL LOU GEHRIGS DISEASE MARKET SEGMENT BY APPLICATION
11.1 Global Lou Gehrigs Disease Sales Market Share by Application (2013-2018)
11.2 Hospital Pharmacies Sales Growth (2013-2018)
11.3 Retail & Online Pharmacie Sales Growth (2013-2018)
12 LOU GEHRIGS DISEASE MARKET FORECAST (2018-2023)
12.1 Global Lou Gehrigs Disease Sales, Revenue and Growth Rate (2018-2023)
12.2 Lou Gehrigs Disease Market Forecast by Regions (2018-2023)
12.2.1 North America Lou Gehrigs Disease Market Forecast (2018-2023)
12.2.2 Europe Lou Gehrigs Disease Market Forecast (2018-2023)
12.2.3 Asia-Pacific Lou Gehrigs Disease Market Forecast (2018-2023)
12.2.4 South America Lou Gehrigs Disease Market Forecast (2018-2023)
12.2.5 Middle East and Africa Lou Gehrigs Disease Market Forecast (2018-2023)
12.3 Lou Gehrigs Disease Market Forecast by Type (2018-2023)
12.3.1 Global Lou Gehrigs Disease Sales Forecast by Type (2018-2023)
12.3.2 Global Lou Gehrigs Disease Market Share Forecast by Type (2018-2023)
12.4 Lou Gehrigs Disease Market Forecast by Application (2018-2023)
12.4.1 Global Lou Gehrigs Disease Sales Forecast by Application (2018-2023)
12.4.2 Global Lou Gehrigs Disease Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
LIST OF TABLES AND FIGURES
Figure Lou Gehrigs Disease Picture
Table Product Specifications of Lou Gehrigs Disease
Figure Global Sales Market Share of Lou Gehrigs Disease by Types in 2017
Table Lou Gehrigs Disease Types for Major Manufacturers
Figure Riluzole Picture
Figure Edaravone (Radicava) Picture
Figure Lou Gehrigs Disease Sales Market Share by Applications in 2017
Figure Hospital Pharmacies Picture
Figure Retail & Online Pharmacie Picture
Figure United States Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure France Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure UK Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure China Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure India Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Table AB Science Basic Information, Manufacturing Base and Competitors
Table AB Science Lou Gehrigs Disease Type and Applications
Table AB Science Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Avicena Group Basic Information, Manufacturing Base and Competitors
Table Avicena Group Lou Gehrigs Disease Type and Applications
Table Avicena Group Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biogen Basic Information, Manufacturing Base and Competitors
Table Biogen Lou Gehrigs Disease Type and Applications
Table Biogen Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BrainStorm Therapeutics Basic Information, Manufacturing Base and Competitors
Table BrainStorm Therapeutics Lou Gehrigs Disease Type and Applications
Table BrainStorm Therapeutics Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Covis Pharmaceutical Inc. Basic Information, Manufacturing Base and Competitors
Table Covis Pharmaceutical Inc. Lou Gehrigs Disease Type and Applications
Table Covis Pharmaceutical Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cytokinetics Inc. Basic Information, Manufacturing Base and Competitors
Table Cytokinetics Inc. Lou Gehrigs Disease Type and Applications
Table Cytokinetics Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eisai Co. Ltd. Basic Information, Manufacturing Base and Competitors
Table Eisai Co. Ltd. Lou Gehrigs Disease Type and Applications
Table Eisai Co. Ltd. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline plc. Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline plc. Lou Gehrigs Disease Type and Applications
Table GlaxoSmithKline plc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ionis Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table Ionis Pharmaceuticals, Inc. Lou Gehrigs Disease Type and Applications
Table Ionis Pharmaceuticals, Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mitsubishi Tanabe Pharma Corp. Basic Information, Manufacturing Base and Competitors
Table Mitsubishi Tanabe Pharma Corp. Lou Gehrigs Disease Type and Applications
Table Mitsubishi Tanabe Pharma Corp. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Neuralstem Inc. Basic Information, Manufacturing Base and Competitors
Table Neuralstem Inc. Lou Gehrigs Disease Type and Applications
Table Neuralstem Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Neuraltus Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table Neuraltus Pharmaceuticals Inc. Lou Gehrigs Disease Type and Applications
Table Neuraltus Pharmaceuticals Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Newron Pharmaceuticals S.p.A. Basic Information, Manufacturing Base and Competitors
Table Newron Pharmaceuticals S.p.A. Lou Gehrigs Disease Type and Applications
Table Newron Pharmaceuticals S.p.A. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Nutra Pharma Corp. Basic Information, Manufacturing Base and Competitors
Table Nutra Pharma Corp. Lou Gehrigs Disease Type and Applications
Table Nutra Pharma Corp. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pharnext SAS Basic Information, Manufacturing Base and Competitors
Table Pharnext SAS Lou Gehrigs Disease Type and Applications
Table Pharnext SAS Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Q-Therapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table Q-Therapeutics Inc. Lou Gehrigs Disease Type and Applications
Table Q-Therapeutics Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Lou Gehrigs Disease Sales by Manufacturer (2016-2017)
Figure Global Lou Gehrigs Disease Sales Market Share by Manufacturer in 2016
Figure Global Lou Gehrigs Disease Sales Market Share by Manufacturer in 2017
Table Global Lou Gehrigs Disease Revenue by Manufacturer (2016-2017)
Figure Global Lou Gehrigs Disease Revenue Market Share by Manufacturer in 2016
Figure Global Lou Gehrigs Disease Revenue Market Share by Manufacturer in 2017
Figure Top 3 Lou Gehrigs Disease Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Lou Gehrigs Disease Manufacturer (Revenue) Market Share in 2017
Figure Global Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Global Lou Gehrigs Disease Revenue and Growth Rate (2013-2018)
Table Global Lou Gehrigs Disease Sales by Regions (2013-2018)
Table Global Lou Gehrigs Disease Sales Market Share by Regions (2013-2018)
Table Global Lou Gehrigs Disease Revenue by Regions (2013-2018)
Figure Global Lou Gehrigs Disease Revenue Market Share by Regions in 2013
Figure Global Lou Gehrigs Disease Revenue Market Share by Regions in 2017
Figure North America Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Europe Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure South America Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure North America Lou Gehrigs Disease Revenue and Growth Rate (2013-2018)
Table North America Lou Gehrigs Disease Sales by Countries (2013-2018)
Table North America Lou Gehrigs Disease Sales Market Share by Countries (2013-2018)
Figure North America Lou Gehrigs Disease Sales Market Share by Countries in 2013
Figure North America Lou Gehrigs Disease Sales Market Share by Countries in 2017
Table North America Lou Gehrigs Disease Revenue by Countries (2013-2018)
Table North America Lou Gehrigs Disease Revenue Market Share by Countries (2013-2018)
Figure North America Lou Gehrigs Disease Revenue Market Share by Countries in 2013
Figure North America Lou Gehrigs Disease Revenue Market Share by Countries in 2017
Figure United States Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Canada Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Mexico Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Europe Lou Gehrigs Disease Revenue and Growth Rate (2013-2018)
Table Europe Lou Gehrigs Disease Sales by Countries (2013-2018)
Table Europe Lou Gehrigs Disease Sales Market Share by Countries (2013-2018)
Table Europe Lou Gehrigs Disease Revenue by Countries (2013-2018)
Figure Europe Lou Gehrigs Disease Revenue Market Share by Countries in 2016
Figure Europe Lou Gehrigs Disease Revenue Market Share by Countries in 2017
Figure Germany Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure UK Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure France Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Russia Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Italy Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Lou Gehrigs Disease Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Lou Gehrigs Disease Sales by Countries (2013-2018)
Table Asia-Pacific Lou Gehrigs Disease Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Lou Gehrigs Disease Sales Market Share by Countries 2017
Table Asia-Pacific Lou Gehrigs Disease Revenue by Countries (2013-2018)
Figure Asia-Pacific Lou Gehrigs Disease Revenue Market Share by Countries 2017
Figure China Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Japan Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Korea Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure India Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Southeast Asia Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure South America Lou Gehrigs Disease Revenue and Growth Rate (2013-2018)
Table South America Lou Gehrigs Disease Sales by Countries (2013-2018)
Table South America Lou Gehrigs Disease Sales Market Share by Countries (2013-2018)
Figure South America Lou Gehrigs Disease Sales Market Share by Countries in 2017
Table South America Lou Gehrigs Disease Revenue by Countries (2013-2018)
Table South America Lou Gehrigs Disease Revenue Market Share by Countries (2013-2018)
Figure South America Lou Gehrigs Disease Revenue Market Share by Countries in 2017
Figure Brazil Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Argentina Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Colombia Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Lou Gehrigs Disease Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Lou Gehrigs Disease Sales by Countries (2013-2018)
Table Middle East and Africa Lou Gehrigs Disease Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Lou Gehrigs Disease Sales Market Share by Countries in 2017
Table Middle East and Africa Lou Gehrigs Disease Revenue by Countries (2013-2018)
Table Middle East and Africa Lou Gehrigs Disease Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Lou Gehrigs Disease Revenue Market Share by Countries in 2013
Figure Middle East and Africa Lou Gehrigs Disease Revenue Market Share by Countries in 2017
Figure Saudi Arabia Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure UAE Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Egypt Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Nigeria Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure South Africa Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Table Global Lou Gehrigs Disease Sales by Type (2013-2018)
Table Global Lou Gehrigs Disease Sales Share by Type (2013-2018)
Table Global Lou Gehrigs Disease Revenue by Type (2013-2018)
Table Global Lou Gehrigs Disease Revenue Share by Type (2013-2018)
Figure Global Riluzole Sales Growth (2013-2018)
Figure Global Riluzole Price (2013-2018)
Figure Global Edaravone (Radicava) Sales Growth (2013-2018)
Figure Global Edaravone (Radicava) Price (2013-2018)
Table Global Lou Gehrigs Disease Sales by Application (2013-2018)
Table Global Lou Gehrigs Disease Sales Share by Application (2013-2018)
Figure Global Retail & Online Pharmacie Sales Growth (2013-2018)
Figure Global Lou Gehrigs Disease Sales, Revenue and Growth Rate (2018-2023)
Table Global Lou Gehrigs Disease Sales Forecast by Regions (2018-2023)
Table Global Lou Gehrigs Disease Market Share Forecast by Regions (2018-2023)
Figure North America Sales Lou Gehrigs Disease Market Forecast (2018-2023)
Figure Europe Sales Lou Gehrigs Disease Market Forecast (2018-2023)
Figure Asia-Pacific Sales Lou Gehrigs Disease Market Forecast (2018-2023)
Figure South America Sales Lou Gehrigs Disease Market Forecast (2018-2023)
Figure Middle East and Africa Sales Lou Gehrigs Disease Market Forecast (2018-2023)
Table Global Lou Gehrigs Disease Sales Forecast by Type (2018-2023)
Table Global Lou Gehrigs Disease Market Share Forecast by Type (2018-2023)
Table Global Lou Gehrigs Disease Sales Forecast by Application (2018-2023)
Table Global Lou Gehrigs Disease Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Figure Lou Gehrigs Disease Picture
Table Product Specifications of Lou Gehrigs Disease
Figure Global Sales Market Share of Lou Gehrigs Disease by Types in 2017
Table Lou Gehrigs Disease Types for Major Manufacturers
Figure Riluzole Picture
Figure Edaravone (Radicava) Picture
Figure Lou Gehrigs Disease Sales Market Share by Applications in 2017
Figure Hospital Pharmacies Picture
Figure Retail & Online Pharmacie Picture
Figure United States Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure France Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure UK Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure China Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure India Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Lou Gehrigs Disease Revenue (Value) and Growth Rate (2013-2023)
Table AB Science Basic Information, Manufacturing Base and Competitors
Table AB Science Lou Gehrigs Disease Type and Applications
Table AB Science Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Avicena Group Basic Information, Manufacturing Base and Competitors
Table Avicena Group Lou Gehrigs Disease Type and Applications
Table Avicena Group Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biogen Basic Information, Manufacturing Base and Competitors
Table Biogen Lou Gehrigs Disease Type and Applications
Table Biogen Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BrainStorm Therapeutics Basic Information, Manufacturing Base and Competitors
Table BrainStorm Therapeutics Lou Gehrigs Disease Type and Applications
Table BrainStorm Therapeutics Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Covis Pharmaceutical Inc. Basic Information, Manufacturing Base and Competitors
Table Covis Pharmaceutical Inc. Lou Gehrigs Disease Type and Applications
Table Covis Pharmaceutical Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cytokinetics Inc. Basic Information, Manufacturing Base and Competitors
Table Cytokinetics Inc. Lou Gehrigs Disease Type and Applications
Table Cytokinetics Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eisai Co. Ltd. Basic Information, Manufacturing Base and Competitors
Table Eisai Co. Ltd. Lou Gehrigs Disease Type and Applications
Table Eisai Co. Ltd. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline plc. Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline plc. Lou Gehrigs Disease Type and Applications
Table GlaxoSmithKline plc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ionis Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table Ionis Pharmaceuticals, Inc. Lou Gehrigs Disease Type and Applications
Table Ionis Pharmaceuticals, Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mitsubishi Tanabe Pharma Corp. Basic Information, Manufacturing Base and Competitors
Table Mitsubishi Tanabe Pharma Corp. Lou Gehrigs Disease Type and Applications
Table Mitsubishi Tanabe Pharma Corp. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Neuralstem Inc. Basic Information, Manufacturing Base and Competitors
Table Neuralstem Inc. Lou Gehrigs Disease Type and Applications
Table Neuralstem Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Neuraltus Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table Neuraltus Pharmaceuticals Inc. Lou Gehrigs Disease Type and Applications
Table Neuraltus Pharmaceuticals Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Newron Pharmaceuticals S.p.A. Basic Information, Manufacturing Base and Competitors
Table Newron Pharmaceuticals S.p.A. Lou Gehrigs Disease Type and Applications
Table Newron Pharmaceuticals S.p.A. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Nutra Pharma Corp. Basic Information, Manufacturing Base and Competitors
Table Nutra Pharma Corp. Lou Gehrigs Disease Type and Applications
Table Nutra Pharma Corp. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pharnext SAS Basic Information, Manufacturing Base and Competitors
Table Pharnext SAS Lou Gehrigs Disease Type and Applications
Table Pharnext SAS Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Q-Therapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table Q-Therapeutics Inc. Lou Gehrigs Disease Type and Applications
Table Q-Therapeutics Inc. Lou Gehrigs Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Lou Gehrigs Disease Sales by Manufacturer (2016-2017)
Figure Global Lou Gehrigs Disease Sales Market Share by Manufacturer in 2016
Figure Global Lou Gehrigs Disease Sales Market Share by Manufacturer in 2017
Table Global Lou Gehrigs Disease Revenue by Manufacturer (2016-2017)
Figure Global Lou Gehrigs Disease Revenue Market Share by Manufacturer in 2016
Figure Global Lou Gehrigs Disease Revenue Market Share by Manufacturer in 2017
Figure Top 3 Lou Gehrigs Disease Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Lou Gehrigs Disease Manufacturer (Revenue) Market Share in 2017
Figure Global Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Global Lou Gehrigs Disease Revenue and Growth Rate (2013-2018)
Table Global Lou Gehrigs Disease Sales by Regions (2013-2018)
Table Global Lou Gehrigs Disease Sales Market Share by Regions (2013-2018)
Table Global Lou Gehrigs Disease Revenue by Regions (2013-2018)
Figure Global Lou Gehrigs Disease Revenue Market Share by Regions in 2013
Figure Global Lou Gehrigs Disease Revenue Market Share by Regions in 2017
Figure North America Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Europe Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure South America Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure North America Lou Gehrigs Disease Revenue and Growth Rate (2013-2018)
Table North America Lou Gehrigs Disease Sales by Countries (2013-2018)
Table North America Lou Gehrigs Disease Sales Market Share by Countries (2013-2018)
Figure North America Lou Gehrigs Disease Sales Market Share by Countries in 2013
Figure North America Lou Gehrigs Disease Sales Market Share by Countries in 2017
Table North America Lou Gehrigs Disease Revenue by Countries (2013-2018)
Table North America Lou Gehrigs Disease Revenue Market Share by Countries (2013-2018)
Figure North America Lou Gehrigs Disease Revenue Market Share by Countries in 2013
Figure North America Lou Gehrigs Disease Revenue Market Share by Countries in 2017
Figure United States Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Canada Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Mexico Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Europe Lou Gehrigs Disease Revenue and Growth Rate (2013-2018)
Table Europe Lou Gehrigs Disease Sales by Countries (2013-2018)
Table Europe Lou Gehrigs Disease Sales Market Share by Countries (2013-2018)
Table Europe Lou Gehrigs Disease Revenue by Countries (2013-2018)
Figure Europe Lou Gehrigs Disease Revenue Market Share by Countries in 2016
Figure Europe Lou Gehrigs Disease Revenue Market Share by Countries in 2017
Figure Germany Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure UK Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure France Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Russia Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Italy Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Lou Gehrigs Disease Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Lou Gehrigs Disease Sales by Countries (2013-2018)
Table Asia-Pacific Lou Gehrigs Disease Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Lou Gehrigs Disease Sales Market Share by Countries 2017
Table Asia-Pacific Lou Gehrigs Disease Revenue by Countries (2013-2018)
Figure Asia-Pacific Lou Gehrigs Disease Revenue Market Share by Countries 2017
Figure China Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Japan Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Korea Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure India Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Southeast Asia Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure South America Lou Gehrigs Disease Revenue and Growth Rate (2013-2018)
Table South America Lou Gehrigs Disease Sales by Countries (2013-2018)
Table South America Lou Gehrigs Disease Sales Market Share by Countries (2013-2018)
Figure South America Lou Gehrigs Disease Sales Market Share by Countries in 2017
Table South America Lou Gehrigs Disease Revenue by Countries (2013-2018)
Table South America Lou Gehrigs Disease Revenue Market Share by Countries (2013-2018)
Figure South America Lou Gehrigs Disease Revenue Market Share by Countries in 2017
Figure Brazil Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Argentina Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Colombia Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Lou Gehrigs Disease Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Lou Gehrigs Disease Sales by Countries (2013-2018)
Table Middle East and Africa Lou Gehrigs Disease Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Lou Gehrigs Disease Sales Market Share by Countries in 2017
Table Middle East and Africa Lou Gehrigs Disease Revenue by Countries (2013-2018)
Table Middle East and Africa Lou Gehrigs Disease Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Lou Gehrigs Disease Revenue Market Share by Countries in 2013
Figure Middle East and Africa Lou Gehrigs Disease Revenue Market Share by Countries in 2017
Figure Saudi Arabia Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure UAE Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Egypt Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure Nigeria Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Figure South Africa Lou Gehrigs Disease Sales and Growth Rate (2013-2018)
Table Global Lou Gehrigs Disease Sales by Type (2013-2018)
Table Global Lou Gehrigs Disease Sales Share by Type (2013-2018)
Table Global Lou Gehrigs Disease Revenue by Type (2013-2018)
Table Global Lou Gehrigs Disease Revenue Share by Type (2013-2018)
Figure Global Riluzole Sales Growth (2013-2018)
Figure Global Riluzole Price (2013-2018)
Figure Global Edaravone (Radicava) Sales Growth (2013-2018)
Figure Global Edaravone (Radicava) Price (2013-2018)
Table Global Lou Gehrigs Disease Sales by Application (2013-2018)
Table Global Lou Gehrigs Disease Sales Share by Application (2013-2018)
Figure Global Retail & Online Pharmacie Sales Growth (2013-2018)
Figure Global Lou Gehrigs Disease Sales, Revenue and Growth Rate (2018-2023)
Table Global Lou Gehrigs Disease Sales Forecast by Regions (2018-2023)
Table Global Lou Gehrigs Disease Market Share Forecast by Regions (2018-2023)
Figure North America Sales Lou Gehrigs Disease Market Forecast (2018-2023)
Figure Europe Sales Lou Gehrigs Disease Market Forecast (2018-2023)
Figure Asia-Pacific Sales Lou Gehrigs Disease Market Forecast (2018-2023)
Figure South America Sales Lou Gehrigs Disease Market Forecast (2018-2023)
Figure Middle East and Africa Sales Lou Gehrigs Disease Market Forecast (2018-2023)
Table Global Lou Gehrigs Disease Sales Forecast by Type (2018-2023)
Table Global Lou Gehrigs Disease Market Share Forecast by Type (2018-2023)
Table Global Lou Gehrigs Disease Sales Forecast by Application (2018-2023)
Table Global Lou Gehrigs Disease Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
